Acumen Pharmaceuticals (ABOS) Prepaid Assets (2020 - 2026)

Acumen Pharmaceuticals (ABOS) has 7 years of Prepaid Assets data on file, last reported at $5.0 million in Q1 2026.

• For the quarter ending Q1 2026, Prepaid Assets fell 13.78% year-over-year to $5.0 million; the trailing twelve-month figure through Mar 2026 stood at $5.0 million (down 13.78% YoY), and the FY2025 full-year result was $5.7 million, down 20.7% from the prior year.
• Prepaid Assets retreated to $5.0 million in Q1 2026, from $5.7 million in the prior quarter.
• In the past five years, Prepaid Assets ranged from a high of $7.2 million in Q4 2024 to a low of $181000.0 in Q3 2023.
• A 5-year average of $3.2 million and a median of $3.6 million in 2023 frame the typical range for Prepaid Assets.
• Peak annual rise in Prepaid Assets reached 1510.55% in 2023, while the deepest fall reached 92.35% in 2023.
• Tracing ABOS's Prepaid Assets over 5 years: stood at $237000.0 in 2022, then surged by 1510.55% to $3.8 million in 2023, then jumped by 89.55% to $7.2 million in 2024, then fell by 20.7% to $5.7 million in 2025, then declined by 12.85% to $5.0 million in 2026.
• Business Quant data shows ABOS's Prepaid Assets at $5.0 million in Q1 2026, $5.7 million in Q4 2025, and $5.5 million in Q3 2025.